Skip to content

ABEO

Abeona Therapeutics Inc.

NASDAQ · USHealthcareBiotechnology
$6.48-7.43%

Price as of Jul 20, 2026

ABEO capital

Abeona Therapeutics Inc. capital & dividend

Leverage, liquidity, debt coverage and shareholder-distribution metrics.

Leverage

Debt / equity
0.16x
Net debt / equity
-0.26x
Debt / assets
0.12x
Debt / EBITDA
0.32x
Net debt / EBITDA
-0.52x

Liquidity & coverage

Current ratio
5.89x
Quick ratio
5.70x
Cash ratio
5.42x
Interest coverage
-25.97x
EBITDA / interest
20.56x
Working capital
$151.9M

Cash & dividend

FCF / debt
-3.68x
Cash flow / debt
-3.35x
Dividend per share
Dividend yield
Dividend growth 1y

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.